Author:
Ørstavik Kristin,Solbakken Gro,Rasmussen Magnhild,Sanaker Petter Schandl,Fossmo Hanne Ludt,Bryne Einar,Knutsen-Øy Torill,Elgsås Tonje,Heiberg Arvid
Publisher
Norwegian Medical Association
Reference26 articles.
1. Liao Q, Zhang Y, He J et al. Global Prevalence of Myotonic Dystrophy: An Updated Systematic Review and Meta-Analysis. Neuroepidemiology 2022; 56: 163–73. [PubMed][CrossRef]
2. Müller KI, Ghelue MV, Lund I et al. The prevalence of hereditary neuromuscular disorders in Northern Norway. Brain Behav 2021; 11: e01948. [PubMed][CrossRef]
3. Johnson NE, Aldana EZ, Angeard N et al. Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1. Neurol Clin Pract 2019; 9: 443–54. [PubMed][CrossRef]
4. Ashizawa T, Gagnon C, Groh WJ et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract 2018; 8: 507–20. [PubMed][CrossRef]
5. Bird TD. Myotonic Dystrophy Type 1. I: Adam MP, Feldman J, Mirzaa GM et al., red. Seattle, WA: GeneReviews, 1993.